TTK Healthcare Q3 2025: Sales Up, Profit Down Significantly

• TTK Healthcare reported standalone net sales of Rs 209.30 crore in December 2025, a 2.22% increase year-over-year.
• Quarterly net profit for December 2025 stood at Rs 10.53 crore, marking a substantial 37.05% decrease from Rs 16.73 crore in December 2024.
• EBITDA declined by 3.76% to Rs 24.57 crore in December 2025 compared to the previous year.
• Earnings Per Share (EPS) decreased to Rs 7.45 in December 2025 from Rs 11.84 in December 2024.
• TTK Healthcare shares closed at Rs 980.70 on January 21, 2026, showing negative returns of -27.52% over 6 months and -26.94% over 12 months.

Why It Matters: TTK Healthcare saw modest sales growth but a significant profit decline in Q3 2025, impacting EPS and share returns.